f | { | f | { |
| "author": "", | | "author": "", |
| "author_email": "cmkandawire@hivmw.org", | | "author_email": "cmkandawire@hivmw.org", |
| "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c", | | "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c", |
| "groups": [], | | "groups": [], |
| "id": "e102b799-dfa8-473c-afa6-08d21fe80556", | | "id": "e102b799-dfa8-473c-afa6-08d21fe80556", |
| "isopen": false, | | "isopen": false, |
| "license_id": "notspecified", | | "license_id": "notspecified", |
| "license_title": "License not specified", | | "license_title": "License not specified", |
| "maintainer": null, | | "maintainer": null, |
| "maintainer_email": null, | | "maintainer_email": null, |
| "metadata_created": "2022-07-25T11:41:13.498786", | | "metadata_created": "2022-07-25T11:41:13.498786", |
n | "metadata_modified": "2022-07-25T11:43:46.345476", | n | "metadata_modified": "2022-07-25T11:45:04.023695", |
| "name": "malawi-integrated-hiv-program-report-2019-q3", | | "name": "malawi-integrated-hiv-program-report-2019-q3", |
| "notes": "* Scale-up of integrated HIV services had reached the | | "notes": "* Scale-up of integrated HIV services had reached the |
| following number of sites:\r\n * __759__ static and __197__ | | following number of sites:\r\n * __759__ static and __197__ |
| outreach HIV testing sites\r\n * __750__ (static) ART sites; | | outreach HIV testing sites\r\n * __750__ (static) ART sites; |
| __615__ of these started at least one pregnant or breastfeeding woman | | __615__ of these started at least one pregnant or breastfeeding woman |
| and 732 started asymptomatic patients (Test & Treat) this quarter\r\n | | and 732 started asymptomatic patients (Test & Treat) this quarter\r\n |
| * __691__ sites with HIV-exposed children in follow-up \r\n* | | * __691__ sites with HIV-exposed children in follow-up \r\n* |
| __1,019,610__ persons were tested for HIV and received their results; | | __1,019,610__ persons were tested for HIV and received their results; |
| __207,831 (20%)__ accessed HIV testing for the first time; __811,779 | | __207,831 (20%)__ accessed HIV testing for the first time; __811,779 |
| (80%)__ were repeat testers and __32,190 (4%)__ of these received | | (80%)__ were repeat testers and __32,190 (4%)__ of these received |
| confirmatory testing (after having tested positive in the past). | | confirmatory testing (after having tested positive in the past). |
| __28,376 (2.8%)__ clients received a positive result for the first | | __28,376 (2.8%)__ clients received a positive result for the first |
| time.\r\n* A total of __30,622__ people received __38,444__ self-test | | time.\r\n* A total of __30,622__ people received __38,444__ self-test |
| kits for either primary or secondary use.\r\n* __14,482 (80%)__ of | | kits for either primary or secondary use.\r\n* __14,482 (80%)__ of |
| 18,018 blood units collected were screened for (at least) HIV, | | 18,018 blood units collected were screened for (at least) HIV, |
| hepatitis B and syphilis\r\n* __168,033 (98%)__ of 172,271 women at | | hepatitis B and syphilis\r\n* __168,033 (98%)__ of 172,271 women at |
| ANC had their HIV status ascertained; __11,669 (7%)__ of these were | | ANC had their HIV status ascertained; __11,669 (7%)__ of these were |
| HIV positive. __149,107 (96%)__ of 155,842 at maternity had their HIV | | HIV positive. __149,107 (96%)__ of 155,842 at maternity had their HIV |
| status ascertained __10,904 (7%)__ of these were HIV positive.\r\n* | | status ascertained __10,904 (7%)__ of these were HIV positive.\r\n* |
| __27,624__ patients started ART this quarter; __80%__ were classified | | __27,624__ patients started ART this quarter; __80%__ were classified |
| as asymptomatic / in WHO stage 1 and started under the \u201cTest & | | as asymptomatic / in WHO stage 1 and started under the \u201cTest & |
| Treat\u201d policy.\r\n* __826,102__ patients were alive and on ART by | | Treat\u201d policy.\r\n* __826,102__ patients were alive and on ART by |
t | end of September 20192. This means that __77%__ of the estimated | t | end of September 2019. This means that __77%__ of the estimated |
| 1,070,896 HIV positive population were on ART. ART coverage was | | 1,070,896 HIV positive population were on ART. ART coverage was |
| __69%__ (46,628/ 67,465) for children and __77%__ (779,474 / | | __69%__ (46,628/ 67,465) for children and __77%__ (779,474 / |
| 1,003,432) for adults.\r\n* __125,766 (93%)__ of viral load results | | 1,003,432) for adults.\r\n* __125,766 (93%)__ of viral load results |
| from routine monitoring were <1000 copies/ml. Viral suppression rates | | from routine monitoring were <1000 copies/ml. Viral suppression rates |
| for routine samples among children (0-14 years) and adults (15+ years) | | for routine samples among children (0-14 years) and adults (15+ years) |
| were __64%__ and __92%__, respectively.\r\n* __72%__ of adults and | | were __64%__ and __92%__, respectively.\r\n* __72%__ of adults and |
| __75%__ of children were retained alive on ART at 12 months after | | __75%__ of children were retained alive on ART at 12 months after |
| initiation.\r\n* Out of __796,167__ patients on first line adult ART | | initiation.\r\n* Out of __796,167__ patients on first line adult ART |
| __286,394 (37%)__ were on TDF/3TC/EFV and __468,880 (60%)__ had | | __286,394 (37%)__ were on TDF/3TC/EFV and __468,880 (60%)__ had |
| transitioned to TDF/3TC/DTG.\r\n* __13,114 6 (>99%)__ of an estimated | | transitioned to TDF/3TC/DTG.\r\n* __13,114 6 (>99%)__ of an estimated |
| 10,932 3 HIV infected pregnant women in Malawi were on ART this | | 10,932 3 HIV infected pregnant women in Malawi were on ART this |
| quarter. __9,521(73%)__ of these were already on ART when getting | | quarter. __9,521(73%)__ of these were already on ART when getting |
| pregnant and __3,593 (27%)__ started ART during pregnancy/delivery.", | | pregnant and __3,593 (27%)__ started ART during pregnancy/delivery.", |
| "num_resources": 1, | | "num_resources": 1, |
| "num_tags": 9, | | "num_tags": 9, |
| "organization": { | | "organization": { |
| "approval_status": "approved", | | "approval_status": "approved", |
| "created": "2021-10-14T11:02:35.234558", | | "created": "2021-10-14T11:02:35.234558", |
| "description": "The Department of HIV & AIDS (DHA) was established | | "description": "The Department of HIV & AIDS (DHA) was established |
| in 2001, initially as a unit in the Department of Clinical Services, | | in 2001, initially as a unit in the Department of Clinical Services, |
| to coordinate the biomedical HIV Program in Malawi. The department now | | to coordinate the biomedical HIV Program in Malawi. The department now |
| carries responsibility for various HIV related programs including: | | carries responsibility for various HIV related programs including: |
| sexually transmitted infections (STIs), prevention of mother to child | | sexually transmitted infections (STIs), prevention of mother to child |
| transmission of HIV (PMTCT), and national voluntary male medical | | transmission of HIV (PMTCT), and national voluntary male medical |
| circumcision program (VMMC). All these HIV program sub-sections are | | circumcision program (VMMC). All these HIV program sub-sections are |
| linked to one robust monitoring and evaluation sub-section in the HIV | | linked to one robust monitoring and evaluation sub-section in the HIV |
| and AIDS Department which technically operates under the Central | | and AIDS Department which technically operates under the Central |
| Monitoring and Evaluation Department (CMED) of the Ministry of | | Monitoring and Evaluation Department (CMED) of the Ministry of |
| Health.", | | Health.", |
| "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "image_url": | | "image_url": |
| 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", |
| "is_organization": true, | | "is_organization": true, |
| "name": "dha", | | "name": "dha", |
| "state": "active", | | "state": "active", |
| "title": "Department of HIV & AIDS and Viral Hepatitis", | | "title": "Department of HIV & AIDS and Viral Hepatitis", |
| "type": "organization" | | "type": "organization" |
| }, | | }, |
| "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "private": false, | | "private": false, |
| "program_area": "Care and Treatment", | | "program_area": "Care and Treatment", |
| "relationships_as_object": [], | | "relationships_as_object": [], |
| "relationships_as_subject": [], | | "relationships_as_subject": [], |
| "resources": [ | | "resources": [ |
| { | | { |
| "cache_last_updated": null, | | "cache_last_updated": null, |
| "cache_url": null, | | "cache_url": null, |
| "created": "2022-07-25T11:43:22.154974", | | "created": "2022-07-25T11:43:22.154974", |
| "description": "Integrated HIV Program Report July-September | | "description": "Integrated HIV Program Report July-September |
| 2019", | | 2019", |
| "format": "PDF", | | "format": "PDF", |
| "hash": "", | | "hash": "", |
| "id": "c0661901-df63-4622-8313-31e9cbc2c35c", | | "id": "c0661901-df63-4622-8313-31e9cbc2c35c", |
| "last_modified": "2022-07-25T11:43:22.115050", | | "last_modified": "2022-07-25T11:43:22.115050", |
| "lfs_prefix": | | "lfs_prefix": |
| "dha/malawi-integrated-hiv-program-report-2019-q3", | | "dha/malawi-integrated-hiv-program-report-2019-q3", |
| "metadata_modified": "2022-07-25T11:43:22.368287", | | "metadata_modified": "2022-07-25T11:43:22.368287", |
| "mimetype": "application/pdf", | | "mimetype": "application/pdf", |
| "mimetype_inner": null, | | "mimetype_inner": null, |
| "name": "Malawi Integrated HIV Program Report 2019 Q3", | | "name": "Malawi Integrated HIV Program Report 2019 Q3", |
| "package_id": "e102b799-dfa8-473c-afa6-08d21fe80556", | | "package_id": "e102b799-dfa8-473c-afa6-08d21fe80556", |
| "position": 0, | | "position": 0, |
| "resource_type": null, | | "resource_type": null, |
| "sha256": | | "sha256": |
| "3fc1d001d80cf10f75eaf41088b60ace09e8cf25621f67e654a117287ecfef67", | | "3fc1d001d80cf10f75eaf41088b60ace09e8cf25621f67e654a117287ecfef67", |
| "size": 4297293, | | "size": 4297293, |
| "state": "active", | | "state": "active", |
| "url": | | "url": |
| e9cbc2c35c/download/malawi_integrated_hiv_program_report_2019-q3.pdf", | | e9cbc2c35c/download/malawi_integrated_hiv_program_report_2019-q3.pdf", |
| "url_type": "upload" | | "url_type": "upload" |
| } | | } |
| ], | | ], |
| "state": "active", | | "state": "active", |
| "tags": [ | | "tags": [ |
| { | | { |
| "display_name": "anc", | | "display_name": "anc", |
| "id": "1e47aae6-8e3d-41e7-9b1a-778af0d2f23a", | | "id": "1e47aae6-8e3d-41e7-9b1a-778af0d2f23a", |
| "name": "anc", | | "name": "anc", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "art", | | "display_name": "art", |
| "id": "ab255b9d-6d35-4789-8ce0-ce10bbe1e299", | | "id": "ab255b9d-6d35-4789-8ce0-ce10bbe1e299", |
| "name": "art", | | "name": "art", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "hiv", | | "display_name": "hiv", |
| "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404", | | "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404", |
| "name": "hiv", | | "name": "hiv", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "htc", | | "display_name": "htc", |
| "id": "3aafcd8e-f836-4e61-9341-8e298f9d1f3a", | | "id": "3aafcd8e-f836-4e61-9341-8e298f9d1f3a", |
| "name": "htc", | | "name": "htc", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "maternity", | | "display_name": "maternity", |
| "id": "cd2b6dc5-5d1f-4a03-91da-9a279e193ed2", | | "id": "cd2b6dc5-5d1f-4a03-91da-9a279e193ed2", |
| "name": "maternity", | | "name": "maternity", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "pmtct", | | "display_name": "pmtct", |
| "id": "06c11980-f1fe-470d-8791-aeee38a117d5", | | "id": "06c11980-f1fe-470d-8791-aeee38a117d5", |
| "name": "pmtct", | | "name": "pmtct", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "report", | | "display_name": "report", |
| "id": "80c23033-8ff3-483d-8aa6-03e39b117372", | | "id": "80c23033-8ff3-483d-8aa6-03e39b117372", |
| "name": "report", | | "name": "report", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "sti", | | "display_name": "sti", |
| "id": "38222aa3-73ca-4ca8-8b42-9a5eb558af5a", | | "id": "38222aa3-73ca-4ca8-8b42-9a5eb558af5a", |
| "name": "sti", | | "name": "sti", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "viral load", | | "display_name": "viral load", |
| "id": "e385a0a4-1722-431f-a657-f9616a14bf6f", | | "id": "e385a0a4-1722-431f-a657-f9616a14bf6f", |
| "name": "viral load", | | "name": "viral load", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| } | | } |
| ], | | ], |
| "title": "Malawi Integrated HIV Program Report 2019 Q3", | | "title": "Malawi Integrated HIV Program Report 2019 Q3", |
| "type": "dataset", | | "type": "dataset", |
| "url": null, | | "url": null, |
| "version": null, | | "version": null, |
| "year": "2019" | | "year": "2019" |
| } | | } |